<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Kumar - Neuropsychiatry Drug Adoption & Causal Impact Analysis</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Crimson+Pro:wght@400;600&family=JetBrains+Mono:wght@400;500&display=swap" rel="stylesheet">
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Crimson Pro', serif;
            line-height: 1.6;
            color: #2c3e50;
            background: #fff;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            padding: 60px 40px;
        }

        .back-link {
            font-family: 'JetBrains Mono', monospace;
            font-size: 0.85rem;
            color: #666;
            text-decoration: none;
            display: inline-block;
            margin-bottom: 40px;
        }

        .back-link:hover {
            color: #2c3e50;
        }

        header {
            margin-bottom: 60px;
            border-bottom: 1px solid #e0e0e0;
            padding-bottom: 30px;
        }

        h1 {
            font-size: 2.2rem;
            font-weight: 600;
            color: #1a1a1a;
            margin-bottom: 15px;
        }

        .subtitle {
            font-size: 1.1rem;
            color: #666;
            margin-bottom: 20px;
        }

        .tags {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            font-family: 'JetBrains Mono', monospace;
            font-size: 0.7rem;
            padding: 4px 10px;
            background: #f5f5f5;
            color: #555;
            border: 1px solid #ddd;
        }

        section {
            margin-bottom: 60px;
        }

        h2 {
            font-size: 1.6rem;
            margin-bottom: 20px;
            color: #1a1a1a;
        }

        h3 {
            font-size: 1.2rem;
            margin-bottom: 15px;
            margin-top: 30px;
            color: #1a1a1a;
        }

        h4 {
            font-size: 1rem;
            margin-bottom: 10px;
            margin-top: 20px;
            color: #1a1a1a;
            font-weight: 600;
        }

        p {
            margin-bottom: 15px;
            color: #555;
            font-size: 1rem;
        }

        ul {
            margin-left: 20px;
            margin-bottom: 15px;
        }

        li {
            margin-bottom: 10px;
            color: #555;
        }

        .architecture-diagram {
            margin: 40px 0;
            padding: 30px;
            background: #fafafa;
            border: 1px solid #e0e0e0;
        }

        .metrics {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 20px;
            margin: 30px 0;
        }

        .metric-card {
            padding: 20px;
            border: 1px solid #e0e0e0;
        }

        .metric-value {
            font-size: 2rem;
            font-weight: 600;
            color: #1a1a1a;
            margin-bottom: 5px;
        }

        .metric-label {
            font-size: 0.9rem;
            color: #666;
        }

        .process-steps {
            margin: 30px 0;
        }

        .step {
            display: grid;
            grid-template-columns: 60px 1fr;
            gap: 20px;
            margin-bottom: 25px;
        }

        .step-number {
            font-family: 'JetBrains Mono', monospace;
            font-size: 1.5rem;
            font-weight: 600;
            color: #999;
        }

        .step-content h4 {
            margin-top: 0;
        }

        .constructs-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 15px;
            margin: 30px 0;
        }

        .construct-item {
            padding: 15px;
            background: #fafafa;
            border: 1px solid #e0e0e0;
        }

        .construct-item h4 {
            margin-top: 0;
            font-size: 0.95rem;
        }

        .drivers-list {
            margin: 30px 0;
            padding: 25px;
            background: #fafafa;
            border: 1px solid #e0e0e0;
        }

        .drivers-list h4 {
            margin-top: 0;
            margin-bottom: 15px;
        }

        code {
            font-family: 'JetBrains Mono', monospace;
            font-size: 0.85rem;
            background: #f5f5f5;
            padding: 2px 6px;
            color: #333;
        }

        @media (max-width: 768px) {
            .container {
                padding: 40px 20px;
            }

            h1 {
                font-size: 1.8rem;
            }

            .metrics,
            .constructs-grid {
                grid-template-columns: 1fr;
            }

            .step {
                grid-template-columns: 40px 1fr;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <a href="index.html" class="back-link">← Back to Portfolio</a>

        <header>
            <h1>Neuropsychiatry Drug Adoption & Causal Impact Analysis</h1>
            <p class="subtitle">Commercial Operations | Propensity-based Modeling</p>
            <div class="tags">
                <span class="tag">Propensity Modeling</span>
                <span class="tag">Recommender Systems</span>
                <span class="tag">Gradient Boosting</span>
                <span class="tag">XGBoost</span>
                <span class="tag">LightGBM</span>
                <span class="tag">Feature Engineering</span>
                <span class="tag">Dual Model Training</span>
                <span class="tag">Feature Importance</span>
                <span class="tag">Feature Intersection</span>
                <span class="tag">SHAP</span>
                <span class="tag">Model Explainability</span>
                <span class="tag">A/B Testing</span>
                <span class="tag">Out-of-Time Validation</span>
                <span class="tag">Backtesting</span>
                <span class="tag">IQVIA SOB</span>
                <span class="tag">IQVIA LAAD</span>
                <span class="tag">Healthcare Analytics</span>
                <span class="tag">HCP Targeting</span>
                <span class="tag">Commercial Operations</span>
                <span class="tag">Pharma Analytics</span>
                <span class="tag">Python</span>
                <span class="tag">scikit-learn</span>
            </div>
        </header>

        <section id="problem">
            <h2>Problem</h2>
            <p>Commercial teams lacked data-driven methods to prioritize healthcare provider (HCP) outreach, resulting in inefficient resource allocation and suboptimal targeting strategies. Manual targeting approaches failed to identify high-potential HCPs likely to prescribe neuropsychiatric medications to new patients.</p>
        </section>

        <section id="solution">
            <h2>Solution</h2>
            <p>Built a gradient-boosted propensity scoring recommender system to identify and rank HCPs most likely to initiate new patients on neuropsychiatric medications. The system integrates prescription behavior, patient demographics, and treatment patterns from commercial data sources to generate actionable HCP recommendations for field teams.</p>
        </section>

        <section id="methodology">
            <h2>Methodology</h2>

            <div class="process-steps">
                <div class="step">
                    <div class="step-number">01</div>
                    <div class="step-content">
                        <h4>Hypothesis Generation</h4>
                        <p>Collaborated with Sales & Marketing to identify 6 key constructs predicting HCP prescribing behavior</p>
                    </div>
                </div>

                <div class="step">
                    <div class="step-number">02</div>
                    <div class="step-content">
                        <h4>Feature Engineering</h4>
                        <p>Integrated IQVIA SOB and LAAD data to create HCP-level behavioral features</p>
                    </div>
                </div>

                <div class="step">
                    <div class="step-number">03</div>
                    <div class="step-content">
                        <h4>Model Development</h4>
                        <p>Dual model training with feature intersection analysis across 50+ iterations</p>
                    </div>
                </div>

                <div class="step">
                    <div class="step-number">04</div>
                    <div class="step-content">
                        <h4>Deployment</h4>
                        <p>Generated propensity scores for field targeting and validated via A/B testing</p>
                    </div>
                </div>
            </div>

            <h3>Key Constructs</h3>
            <div class="constructs-grid">
                <div class="construct-item">
                    <h4>HCP Characteristics</h4>
                </div>
                <div class="construct-item">
                    <h4>Prescription Behavior</h4>
                </div>
                <div class="construct-item">
                    <h4>Patient Mix</h4>
                </div>
                <div class="construct-item">
                    <h4>Market Access</h4>
                </div>
                <div class="construct-item">
                    <h4>Engagement Patterns</h4>
                </div>
                <div class="construct-item">
                    <h4>Approach to Treatment</h4>
                </div>
            </div>

            <h3>Feature Selection Strategy</h3>
            <p>To ensure model robustness and minimize overfitting, implemented a dual model training approach:</p>
            <ul>
                <li>Trained two independent gradient boosting models on different data splits</li>
                <li>Extracted feature importance rankings from both models</li>
                <li>Selected only features appearing in top rankings across both models (intersection analysis)</li>
                <li>Validated feature stability across 50+ model iterations</li>
                <li>Achieved ~90% overlap in top 10 features, ~80% in top 20, and ~75% in top 50</li>
            </ul>
        </section>

        <section id="architecture">
            <h2>Architecture</h2>

            <div class="architecture-diagram">
                <div style="font-family: 'JetBrains Mono', monospace; font-size: 0.85rem; line-height: 1.8;">
                    <div style="margin-bottom: 20px;">
                        <strong>Data Sources</strong><br>
                        IQVIA SOB<br>
                        IQVIA LAAD
                    </div>
                    
                    <div style="text-align: center; color: #999; margin: 10px 0;">↓</div>
                    
                    <div style="margin-bottom: 20px;">
                        <strong>Feature Engineering</strong><br>
                        6 Key Constructs
                    </div>
                    
                    <div style="text-align: center; color: #999; margin: 10px 0;">↓</div>
                    
                    <div style="margin-bottom: 20px;">
                        <strong>Model A</strong> (Gradient Boosting) | <strong>Model B</strong> (Gradient Boosting)
                    </div>
                    
                    <div style="text-align: center; color: #999; margin: 10px 0;">↓</div>
                    
                    <div style="margin-bottom: 20px;">
                        <strong>Feature Intersection</strong><br>
                        50+ Iterations
                    </div>
                    
                    <div style="text-align: center; color: #999; margin: 10px 0;">↓</div>
                    
                    <div style="margin-bottom: 20px;">
                        <strong>Final Model</strong><br>
                        Propensity Scores<br>
                        SHAP Analysis
                    </div>
                    
                    <div style="text-align: center; color: #999; margin: 10px 0;">↓</div>
                    
                    <div>
                        <strong>Validation</strong><br>
                        Out-of-Time Testing<br>
                        A/B Testing
                    </div>
                </div>
            </div>

            <div class="drivers-list">
                <h4>Representative Top Drivers</h4>
                <ul style="margin-left: 20px; margin-bottom: 0;">
                    <li>HCP Specialty</li>
                    <li>Adopter Status</li>
                    <li>Patient Switching</li>
                    <li>Prescription Share</li>
                    <li>Payer Mix</li>
                    <li>Patient Demographics</li>
                    <li>Treatment Patterns</li>
                </ul>
            </div>
        </section>

        <section id="implementation">
            <h2>Implementation</h2>

            <h3>Data Integration</h3>
            <p>Integrated prescription dispensing data (IQVIA SOB) with claims-level patient data (IQVIA LAAD) to construct comprehensive HCP behavioral profiles. Feature engineering translated domain hypotheses into quantitative signals across prescription patterns, patient demographics, treatment approaches, and market access characteristics.</p>

            <h3>Model Development</h3>
            <p>Implemented gradient boosting (XGBoost/LightGBM) with a dual model training strategy to ensure robust feature selection. Trained two independent models on different data partitions, then selected features appearing in top importance rankings across both models. This intersection approach minimized overfitting and improved generalization to unseen HCPs.</p>

            <h3>Explainability</h3>
            <p>Applied SHAP (SHapley Additive exPlanations) analysis to generate individual HCP-level explanations for both high-propensity and low-propensity prescribers. These explanations enabled commercial teams to understand which behavioral patterns drove model predictions and identify hidden opportunities where low-scoring HCPs converted despite model predictions.</p>

            <h3>Validation Framework</h3>
            <p><strong>Out-of-Time Backtesting:</strong> Validated model performance by training on historical periods and testing on future held-out periods the model had not seen. This temporal validation ensured the model could accurately predict HCP behavior in prospective deployment scenarios.</p>
            <p><strong>Prospective A/B Testing:</strong> Field validation methodology under development to measure real-world impact of model-driven targeting versus standard approaches.</p>
        </section>

        <section id="results">
            <h2>Results</h2>

            <div class="metrics">
                <div class="metric-card">
                    <div class="metric-value">0.77</div>
                    <div class="metric-label">PR-AUC</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">5-7%</div>
                    <div class="metric-label">Conversion Rate Lift</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">50+</div>
                    <div class="metric-label">Model Iterations</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">~90%</div>
                    <div class="metric-label">Top 10 Feature Overlap</div>
                </div>
            </div>

            <p>The recommender system achieved strong precision-recall performance (0.77 PR-AUC) and demonstrated 5-7% lift in HCP conversion rates compared to baseline targeting approaches. Feature stability analysis across iterations showed ~90% consistency in top 10 drivers, ~80% in top 20, and ~75% in top 50, validating the robustness of the dual model selection strategy.</p>

            <p>SHAP analysis revealed interpretable patterns: high-propensity HCPs exhibited specific combinations of specialty type, prior adoption behavior, and patient switching patterns. Analysis of low-propensity HCPs who nevertheless converted uncovered hidden opportunities and edge cases not captured by initial feature engineering, informing subsequent model refinements.</p>
        </section>

        <a href="index.html" class="back-link">← Back to Portfolio</a>
    </div>
</body>
</html>
